Le Lézard
Classified in: Health
Subject: NPT

ECRI Institute Provides New Answers for Hospitals Coping with Critical IV-Fluid Minibag Shortage


PLYMOUTH MEETING, Pa., Jan. 19, 2018 /PRNewswire-USNewswire/ -- Hurricane Maria and its 100-plus-mph winds took no pity on Puerto Rico. In the aftermath of the hurricane, the island experienced extreme devastation, affecting production of life-saving medical products by manufacturers throughout the island.

ECRI Institute logo. (PRNewsFoto/ECRI Institute)

IV-fluid minibags, mainly manufactured in Puerto Rico, are widely used 50-250 mL solution bags that infuse antibiotics and other medications intravenously. The minibag shortage impacts hospitals nationwide, hindering normal patient care, and pharmacy and nursing practices.

As part of its dedication to provide healthcare resources to the public, ECRI Institute announces the release of a special Health Devices guidance article featuring recommendations and alternative solutions for coping with the minibag shortage. The guidance article also features functional equivalency data for IV solution bags. This data employs the brainpower of ECRI Institute's CrossCHEQ service, which identifies acceptable alternatives for medical-surgical supplies and implants.

"ECRI Institute is providing trusted guidance to help hospitals across the country combat this critical shortage," says Juuso Leinonen, senior project engineer, Health Devices, ECRI Institute. "Furthermore, our CrossCHEQ list of alternative suppliers equips hospitals with the information they need to take quick action to keep patients safe."

The publicly available guidance article identifies alternative products from B. Braun Medical Inc., Baxter International, Fresenius Kabi, and Hospira Inc. Links to resources from the Institute for Safe Medication Practices (ISMP) and the American Society of Health-System Pharmacists (ASHP) are included in the report.

Learn more about ECRI Institute's Health Devices technology evaluation program and CrossCHEQ, an unbiased resource that identifies functional equivalents for medical-surgical supplies and implants. For additional information, contact ECRI Institute by telephone at (610) 825-6000; by e-mail at [email protected]; or by mail at 5200 Butler Pike, Plymouth Meeting, PA 19462 USA. 

Social sharing

About ECRI Institute
ECRI Institute (www.ecri.org), a nonprofit organization, dedicates itself to bringing the discipline of applied scientific research to healthcare to discover which medical procedures, devices, drugs, and processes enable improved patient care. As pioneers in this science for nearly 50 years, ECRI Institute marries experience and independence with the objectivity of evidence-based research. Strict conflict-of-interest guidelines ensure objectivity. ECRI Institute is designated an Evidence-based Practice Center by the U.S. Agency for Healthcare Research and Quality. ECRI Institute PSO is listed as a federally certified Patient Safety Organization by the U.S. Department of Health and Human Services. Find ECRI Institute on Facebook (www.facebook.com/ECRIInstitute) and on Twitter (www.twitter.com/ECRI_Institute).

SOURCE ECRI Institute


These press releases may also interest you

at 16:19
Unifor expects to achieve the wage increases and benefit improvements awarded to Ontario OCHU-CUPE and SEIU Healthcare members by Arbitrator William Kaplan in a recent decision....

at 16:10
Acadia Pharmaceuticals Inc. today announced that on April 10, 2024, the Compensation Committee of Acadia's Board of Directors (the "Committee") granted inducement awards consisting of non-qualified stock options to purchase 21,659 shares of common...

at 16:10
Calidi Biotherapeutics, Inc. , a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced the closing of its previously announced public offering of 15,197,500 shares of common stock (or pre-funded...

at 15:55
Valley Mountain Regional Center ("VMRC") experienced a data security incident that involved personal and / or protected health information belonging to certain current and former patients and has provided notice of this incident to impacted...

at 15:44
Late yesterday the United States District Court for the Northern California ruled that CVS acted intentionally under the "deliberate indifference" standard when it implemented a drug program that discriminates against people living with HIV....

at 15:33
Alameda Health System needs help identifying a patient who arrived at the Wilma Chan Highland Hospital Campus on March 15, 2024, without identification....



News published on and distributed by: